Feasibility study of a general model for synthetic CT generation in MRI-guided extracranial radiotherapy.
Authors
Affiliations (2)
Affiliations (2)
- Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States of America.
- Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, United States of America.
Abstract
This study aims to investigate the feasibility of a single general model to synthesize CT images across body sites, thorax, abdomen, and pelvis, to support treatment planning for MRI-only radiotherapy. A total of 157 patients who received MRI-guided radiation therapy in the thorax, abdomen, and pelvis on a 0.35T MRIdian Linac were included. A subset of 122 cases were used for model training and the remaining 35 cases were used for model validation. All patient datasets had semi-paired CT-simulation image and 0.35T MR image acquired using TrueFISP. A conditional generative adversarial network with a multi-planar method was used to generate synthetic CT images from 0.35T MR images. The effect of preprocessing methods (with and without bias field corrections) on the quality of synthetic CT was evaluated and found to be insignificant. The general models trained on all cases performed comparably to the site-specific models trained on individual body sites. For all models, the peak signal-to-noise ratios ranged from 31.7 to 34.9 and the structural index similarity measures ranged from 0.9547 to 0.9758. For the datasets with bias field corrections, the mean-absolute-errors in HU (general model versus site-specific model) were 49.7 ± 9.4 versus 49.5 ± 8.9, 48.7 ± 7.6 versus 43 ± 7.8 and 32.8 ± 5.5 versus 31.8 ± 5.3 for the thorax, abdomen, and pelvis, respectively. When comparing plans between synthetic CTs and ground truth CTs, the dosimetric difference was on average less than 0.5% (0.2 Gy) for target coverage and less than 2.1% (0.4 Gy) for organ-at-risk metrics for all body sites with either the general or specific models. Synthetic CT plans showed good agreement with mean gamma pass rates of >94% and >99% for 1%/1 mm and 2%/2 mm, respectively. This study has demonstrated the feasibility of using a general model for multiple body sites and the potential of using synthetic CT to support an MRI-guided radiotherapy workflow.